Sucrose Gradient Sedimentation Analysis of Mitochondrial Ribosomes
- PMID: 33230776
- PMCID: "V体育ios版" PMC8281390
- DOI: 10.1007/978-1-0716-0834-0_16
V体育平台登录 - Sucrose Gradient Sedimentation Analysis of Mitochondrial Ribosomes
Abstract
Mitochondria contain ribosomes (mitoribosomes) specialized in the synthesis of a handful of proteins essential for oxidative phosphorylation. Therefore, mitoribosome integrity and function are essential for the life of eukaryotic cells and lesions that affect them result in devastating human disorders VSports手机版. To broadly analyze the integrity and assembly state of mitoribosomes it is useful to start by determining the sedimentation profile of these structures by sucrose gradient centrifugation of mitochondrial extracts. During centrifugation, mitoribosome subunits, monosomes and polysomes, and potentially accumulated assembly intermediates will sediment through the gradient at different rates. Sedimentation will depend on the centrifugal force applied and the density and viscosity of the gradient. Importantly, it will also depend on the size, shape, and density of the mitoribosome particles present in the samples under study. Variations of this technique, often coupled with additional downstream approaches, have been used to analyze the process of mitoribosome biogenesis, the composition of assembly intermediates, or to monitor the interaction of extraribosomal proteins with individual mitoribosome subunits or monosomes. .
Keywords: Gradient fractionation; Gradient maker; Gradient master; Immunoblotting; Mitochondrial ribosome; Mitoribosome profile; Sucrose gradient. V体育安卓版.
Figures


References
-
- Margulis L (1975) Symbiotic theory of the origin of eukaryotic organelles; criteria for proof. Symp. Soc. Exp. Biol, 29, 21–38. - PubMed
-
- Greber BJ, Bieri P, Leibundgut M, Leitner A, Aebersold R, Boehringer D and Ban N (2015) Ribosome. The complete structure of the 55S mammalian mitochondrial ribosome. Science, 348, 303–308. - PubMed
-
- Lightowlers RN, Taylor RW and Turnbull DM (2015) Mutations causing mitochondrial disease: What is new and what challenges remain? Science, 349, 1494–1499. - PubMed
-
- Murphy MP and Hartley RC (2018) Mitochondria as a therapeutic target for common pathologies. Nature reviews. Drug discovery, 5, 174. - PubMed
Publication types
- Actions (V体育2025版)
MeSH terms
- V体育安卓版 - Actions
- "VSports最新版本" Actions
- "VSports注册入口" Actions
- VSports在线直播 - Actions
- Actions (V体育2025版)
VSports在线直播 - Substances
- V体育官网 - Actions
Grants and funding
LinkOut - more resources
"VSports最新版本" Full Text Sources